COMMUNIQUÉS West-GlobeNewswire

Kallelse till årsstämma för C-RAD AB (publ)
16/04/2018
Aktie ä garna i C-RAD AB (publ), org. nr 556663-9174 ( ” Bolaget ” ), kallas h ä rmed till å rsst ä mma torsdagen den 17 maj 2018 klockan 10.00 p å Clarion Hotel Gillet, Dragarbrunnsgatan 23 i Uppsala. Rätt att deltaga [...]
AIT Therapeutics Names Stephen J. DiPalma as Chief Financial Officer
16/04/2018
Industry veteran brings over 30 years of experience to AIT NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on [...]
Alder BioPharmaceuticals® Appoints Erin Lavelle to Newly Created Role of Chief Operating Officer
16/04/2018
Continues to Build Executive Team and Position Company for Next Stage of Growth and Development BOTHELL, Wash., April 16, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ) (“Alder” or the “Company [...]
Cerner to Release First Quarter 2018 Earnings Results May 2
16/04/2018
KANSAS CITY, Mo. , April 16, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced it will release its first quarter 2018 earnings results after the market closes Wednesday, May 2. Following the [...]
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
16/04/2018
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that along with its collaborators, it has achieved several breakthrough capabilities for its 3D [...]
Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating the Ability of its PDCs to Selectively Target a Broad Range of Tumor Cells
16/04/2018
MADISON, Wis., April 16, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis
16/04/2018
NORCROSS, Ga., April 16, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today provided highlights from a late-breaker oral [...]
Foamix Announces $16 Million Investment by OrbiMed
16/04/2018
REHOVOT, Israel and BRIDGEWATER, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Preclinical Data Highlighting Uptake and Enhanced Anti-Tumor Effects of Cellectar’s CLR 131 in Head and Neck Cancer Presented at AACR Annual Meeting
16/04/2018
MADISON, Wis., April 16, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]
Melinta Therapeutics to Present Detailed Results from Vabomere TANGO II Trial as well as New In Vitro and In Vivo Findings from Baxdela and Pyrrolocytosine Candidate at ECCMID 2018
16/04/2018
NEW HAVEN, Conn., April 16, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Spero Therapeutics Highlights SPR741 Phase 1 and Preclinical Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases
16/04/2018
Eight presentations on SPR741 at ECCMID, collectively supporting its activity, safety and tolerability CAMBRIDGE, Mass., April 16, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset [...]
XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology
16/04/2018
XBiotech to Launch Two Phase 2 Clinical Studies to Study Subcutaneous Administration of MABp1 for Treatment of Hidradenitis Suppurativa and Atopic Dermatitis AUSTIN, Texas, April 16, 2018 (GLOBE NEWSWIRE) -- XBiotech [...]
Extendicare Announces April 2018 Dividend of C$0.04 per Share
16/04/2018
MARKHAM, Ontario, April 16, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Advanced Proteome Therapeutics Announces CEO and Director Resignations
16/04/2018
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“ APC ” or the “ Company ”) (TSX-V: APC ) (FSE:0E8) announces that its Board of Directors has accepted the [...]
Emblem Continues to Bolster Professional Leadership Team with Three Strategic Hires to Grow Market Share
16/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) , a leading [...]
Tabula Rasa HealthCare Subsidiary CareKinesis is Exclusive Provider of In-Home Medication Reminder Device for PACE Organizations
16/04/2018
MOORESTOWN, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC ), a healthcare technology company that develops and employs medication risk mitigation software solutions and tools [...]
eFFECTOR Presents Data on the Discovery and Structure of eFT226, a Novel Inhibitor of eIF4A, at the AACR 2018 Annual Meeting
16/04/2018
eFFECTOR will also Present Two Posters Validating the Immunological Profile of eFT508 SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation [...]
Easton Pharmaceuticals Announces BAYER Agreement Update
16/04/2018
TORONTO, ON, April 16, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Announces update to its signed agreement with BAYER’s subsidiary company, Bayer Consumer Care. As previously announced, Easton [...]
Sun BioPharma, Inc. Announces Appointment of Susan Horvath as Vice President of Finance and Chief Financial Officer
16/04/2018
MINNEAPOLIS, April 16, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today announced [...]

Pages